Background: Psoriasis has a significant impact on quality of life (QoL). Sexual life can also be affected, with sexual dysfunction being reported by 25-70% of patients. oBjectives: To determine the occurrence of sexual dysfunction and evaluate QoL in women with psoriasis. Methods: This case-control study included women aged 18-69 years. The validated Brazilian Portuguese versions of the Female Sexual Function Index (FSFI) and of the Medical Outcomes Study 36-Item Short Form Health Survey (SF-36) were administered to all participants to assess sexual function and QoL, respectively. Patients with psoriasis underwent clinical evaluation for the presence of comorbidities, especially psoriatic arthritis and other rheumatic manifestations. Location of lesions and the extent of skin involvement were also assessed. results: The sample consisted of 150 women, 75 with diagnosis of psoriasis and 75 healthy controls. Prevalence of sexual dysfunction was high in women with psoriasis (58.6% of the sample). Prevalence was statistically higher in women with psoriasis than in controls (P = 0.014). The SF-36 domain scores were also lower in women with psoriasis, with role limitations due to physical health, limitations due to emotional problems, and mental health being the most affected domains. study liMitations: Sample size was calculated to evaluate the association between the occurrence of sexual dysfunction and psoriasis, but it did not include the determination of the possible causes of this dysfunction. conclusions: QoL and sexual function were altered in women with psoriasis and should be taken into consideration when assessing disease severity.
INTRODUCTION
Psoriasis is a chronic systemic inflammatory disease that involves mainly the skin and joints, affecting 1-3% of the world population. [1] [2] [3] In Brazil, there are still no studies on its incidence and prevalence, but it is estimated that 1% of the Brazilian population has psoriasis. 4 Its impact on quality of life (QoL) has been studied since the 1970s, when Jobling observed that more than 80% of patients presented difficulties in establishing social relations, considered the most daunting aspect of their illness. 5, 6 Since then, interest has in- investigAtion Kurizky 
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of depression, shame, and anxiety, culminating in social isolation. [7] [8] [9] [10] [11] Al-Mazeedi et al. reported that psoriasis inhibited new relations in 48 .2% of patients, and two-thirds were concerned about the reactions and perceptions of others in relation to their condition. 8 One of the key points in maintaining QoL, as defined by the World Health Organization, is sexuality. 12 Sexual dysfunction is characterized by lack of adequate functioning of one of the phases comprising the sexual cycle. In women, sexual dysfunction is defined as disorders of desire, libido, or arousal, pain or discomfort, and anorgasmia. 13 Although sexual dysfunction is a common complaint, affecting 30 to 70% of psoriasis patients, few studies have analyzed the impact of psoriasis and psoriatic arthritis on quality of sexual life, and none has addressed the Brazilian population. 14, 15 The aim of this article was to assess the occurrence of sexual dysfunction in psoriasis using a case-control study with Brazilian women. org/). The Kolmogorov-Smirnov test for normality was used to verify whether the sample's data showed normal distribution. The distribution was considered normal if p>0.05. Analysis of categorical variables was based on the chi-square test of independence. When data for the variables were less than five, the p-value from the Monte Carlo simulated Fisher's exact test was used, as proposed by Hope, 1968. 21 The association between quantitative variables was investigated in two ways: a) by means of categorization of the variables, followed by analysis using the chi-square test or Monte Carlo simulated p-value; b) by calculation of Pearson's correlation coefficient, when the variables showed two-tailed normal distribution, or Spearman's rank correlation coefficient for cases that did not show this distribution.
METHODS
Finally, analysis of covariance was applied to assess quantitative target variables from FSFI and SF-36, adjusted for covariables that could influence the study's results. The categories of some covariables were grouped so as to increase the model's explanatory capacity and goodness of fit. Statistical significance was set at 5%. Analysis of the association between diagnosis of psoriasis and each of the domains (desire, arousal, lubrication, orgasm, satisfaction, and pain), separately, adjusted for age, race, schooling, and marital status was done by analysis of covariance. Table 4 shows that the statistical difference was maintained, evidencing that the score in the control group was higher than in the group of psoriasis patients for all the domains. sun-bathing were affected in half of the cases, and light exercises, such as walking, were jeopardized in 77.3% of patients. 8 The functional limitation is due mainly to pruritis, irritation, and pain. Palmoplantar psoriasis and psoriatic arthritis add a negative effect to QoL, since they directly affect activities of daily living. 8 According to Chiozza, psoriasis patients, more than patients with other dermatologic diagnoses, fear social isolation and rejection and harbor fantasies of abandonment. 24 Approximately 26% of psoriasis patients report family tensions resulting from the disease, 50% limit their participation in sports activities, and 40%
RESULTS
experience some difficulty in the workplace. 25 A recent systematic literature review aimed to assess the prevalence of sexual dysfunction in patients with psoriasis and psoriatic arthritis, analyzing such factors as depression and extent of the disease in this relationship. 26 The review analyzed 4,039 psoriasis patients, of whom 2,567 were men (63.55%) and 1,472 were women (36.45%), with age ranging from 23 to 62 years. In all the studies, patients were assessed as to sexual function based on self-administered questionnaires, and some studies also evaluated psychological aspects and QoL. Although the study populations and questionnaires varied, sexual dysfunction was prevalent in all the studies (ranging from 22.6% to 71.3%).
26
Later publications also addressed the subject, with prevalence of sexual dysfunction ranging from 50% to 65%. 15. 27-31 Prevalence of sexual dysfunction in our patients was high (58.6%), statistically higher than in the control group (38.6%). This difference was maintained in the analysis of the association between diagnosis of psoriasis and each of the domains separately (desire, arousal, lubrication, orgasm, satisfaction, and pain), adjusted by age, race, schooling, and marital status, showing that sexual dysfunction is more frequent in the group of psoriasis patients in all the domains.
Analysis of the psoriasis group showed that patients reporting sexual dysfunction also presented more extensive skin lesions.
This same relationship had been observed by Sampogna et al. in 2007 32 , later confirmed by Guenther et al. in 2011, 33 although it is not a consensus. 8, 13, 25, 30, [34] [35] [36] [37] Various factors can impact the quality of sexual life in psoriasis patients, including side effects of medications, increased prevalence of comorbidities, 38 lesion site, and symptoms of the skin condition itself, such as pruritis, psychological alterations, and the partner's concerns 33 Comorbidities were prevalent in the psoriasis group, as reported in previous studies. 39, 40 Previous studies have reported a relationship between chronic diseases, especially rheumatic comorbid- Some limitations to the current study need to be addressed.
First, although previous diagnoses of psychiatric disorders such as depression and anxiety were an exclusion factor, no specific psychiatric tests were applied.
Second, corroborating the literature, this group of patients with psoriasis also showed a high comorbidity rate (64%), including diabetes mellitus and hypertension, chronic conditions that are known to be associated with increased sexual dysfunction. Although prior sample calculation was performed to determine the number needed to assess the association between psoriasis and sexual dysfunction, the calculation did not cover the determination of the possible causes of such dysfunction. Thus, to determine the real influence of factors like emotional alterations and comorbidities, especially rheumatic diseases, a larger sample would probably be necessary. In addition, the complete exclusion of women with arthritis from the control group was intended to avoid the possibility of rare cases of psoriatic arthritis preceding cutaneous manifestation from being included erroneously in this group. However, this made the sample intentional, which can also be considered a bias.
CONCLUSION
Despite its limitations, our study was the first of its kind in female Brazilian patients, and the results proved important to confirm the impact of psoriasis on QoL, to identify the domains most affected, and to elucidate the relationship between this disease and alterations in sexual function. The high prevalence of sexual dysfunction in our patients highlights the need for a more comprehensive approach to the health of women with psoriasis, beyond assessment of their skin condition and the extent of the disease, including other QoL issues and specifically sexual function. q
